2019
DOI: 10.1097/md.0000000000017983
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous infusion of dexmedetomidine amplifies thoracic epidural analgesic effect after open thoracotomy

Abstract: Background: The anesthetic-sparing effect of dexmedetomidine has led to its use as a general adjuvant. The present study aimed to determine intravenous infusion of dexmedetomidine to epidural analgesia after open thoracotomy. Methods: Forty-four patients scheduled for admission to the intensive care unit after open thoracotomy were divided into 2 groups. An epidural catheter was placed at T4 to T7. Thirty minutes before the end of thoracotomy, group D w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…Thoracic paravertebral nerve block anesthesia is a commonly used anesthesia method in thoracic surgery, with a high safety profile. It is also conducive to maintaining hemodynamic stability and analgesic effect [ 3 ]. Ropivacaine is a commonly used local anesthesia drug characterized by convenient use and ideal analgesic effect, while dexmedetomidine is a highly selective adrenergic α 2 receptor agonist with a good efficacy profile in antianxiety, sedation, and analgesia [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thoracic paravertebral nerve block anesthesia is a commonly used anesthesia method in thoracic surgery, with a high safety profile. It is also conducive to maintaining hemodynamic stability and analgesic effect [ 3 ]. Ropivacaine is a commonly used local anesthesia drug characterized by convenient use and ideal analgesic effect, while dexmedetomidine is a highly selective adrenergic α 2 receptor agonist with a good efficacy profile in antianxiety, sedation, and analgesia [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Literature Findings. The literature supports the use of intravenous dexmedetomidine as an analgesic adjunct intraoperatively [112][113][114][115] and/or postoperatively 113,114,116,117 for patients undergoing thoracic surgery via VATS 112,113,115,117 and thoracotomy 114,116,117 as it reduces pain scores 112,114,116 and/or opioid 113,[115][116][117] consumption (Category A2-B evidence).…”
Section: A 2 Ementioning
confidence: 94%
“…Dexmedetomidine is a central alpha-2-agonist with sedative, analgesic and opioid-sparing properties (59). One study illustrated that a low-dose intravenous infusion of dexmedetomidine initiated before the end of surgery and continued for 12 h after thoracotomy amplified TEA (60). Patients receiving dexmedetomidine expressed lower Visual Analog Pain (VAS) scores during the first 48 h after surgery despite using fewer opioid analgesics.…”
Section: Part 2: Multimodal Analgesiamentioning
confidence: 99%
“…Additionally, this effect is further enhanced by the addition of perineural dexamethasone (62). Intraoperative dexmedetomidine also reduces the incidence of emergence agitation and cough after thoracic surgery, although, time to awakening from anesthesia may be prolonged and bradycardia may be observed (60,61,63). Dexmedetomidine presents significant benefits in terms of analgesia and quality of recovery after thoracic surgery and its use should be considered.…”
Section: Part 2: Multimodal Analgesiamentioning
confidence: 99%